missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Please login to your online account to display your discounted pricing
Quidel Sofia 2 Flu+SARS Antigen FIA (25T)
Uses advanced immunofluorescence-based lateral flow technology in a sandwich design for qualitative detection of nucleocapsid protein from influenza A and influenza B, and SARS-CoV-2. Allows for testing of patients suspected of influenza A, influenza B, and COVID-19/2019-nCoV at the Point of Care.
Supplier: Quidel Q20380
Description
- One Sample - Three Results
- Results in 15 minutes
- Dual Work Modes
- Virena Connection
- All necessary components included in kit
- Self-contained Test cassette
- For use with Sofia 2
- FDA Emergency Use Authorization.
Specifications
| End-User Placement Agreement Required | |
| Included and available for purchase | |
| Waived (EUA) | |
| Direct: Nasal Swab, Nasopharyngael Swab | |
| Rapid Test | |
| 12 Kits/Cs. | |
| Influenza A: NS - 95%, NPS - 94.6%Influenza B: NS - 96%, NPS - 97%SARS-CoV-2: 100% | |
| Liquid |
| 15°C to 35°C | |
| No | |
| Influenza A and B, COVID-19/2019-nCOV | |
| Influenza A: NS - 90%, NPS - 97.1%Influenza B: NS - 89%, NPS - 90%SARS-CoV-2: 95.2% | |
| Instrument Read - advanced immunofluorescence-based lateral flow | |
| 25 | |
| 15 min. |